Form 4: Vita Coco Executive Chairman Sells Shares
Insider Transaction Report
Michael Kirban, Executive Chairman of Vita Coco Company, Inc., sold 20,000 shares of common stock for a weighted average price of $41.535 under a Rule 10b5-1 trading plan.
Summary
- Michael Kirban, Executive Chairman of Vita Coco Company, Inc. (COCO), reported a sale of 20,000 shares of common stock.
- The transaction occurred on September 22, 2025, at a weighted average price of $41.535 per share, with prices ranging from $41.50 to $41.60.
- The sale was executed pursuant to a pre-arranged Rule 10b5-1 trading plan.
- Following the transaction, Michael Kirban directly beneficially owns 127,629 shares of common stock.
- He also indirectly beneficially owns 1,529,049 shares through the Michael Kirban 2010 Trust and 615,681 shares through the Michael Kirban Revocable Trust.
- Michael Kirban holds various non-qualified stock options, including 546,000 shares at an exercise price of $10.178 (fully vested), 40,950 shares at $10.178 (fully vested), 298,507 shares at $15 (vesting in four equal annual installments beginning November 27, 2022), 46,875 shares at $16.91 (vesting beginning March 10, 2024), 62,743 shares at $26.18 (vesting beginning March 4, 2025), and 70,715 shares at $32.78 (vesting beginning March 3, 2026).
Sentiment
Score: 5
Explanation: The filing reports a pre-planned insider sale of common stock, which is a routine disclosure. While it reduces direct insider ownership, the sale was executed under a Rule 10b5-1 plan, suggesting it was not based on new material non-public information. This makes the sentiment neutral.
Negatives
- The transaction represents a reduction in direct beneficial ownership by a key executive.
- Insider selling, even if pre-planned, can sometimes be perceived negatively by the market, though a Rule 10b5-1 plan mitigates this concern.
Future Outlook
The filing indicates future vesting schedules for several non-qualified stock options held by Michael Kirban, with annual installments for certain options beginning in March 2025 and March 2026, and expiration dates extending to March 2035.
Industry Context
This Form 4 filing is a routine disclosure of an insider stock transaction and does not provide information related to broader industry trends or the competitive landscape for the beverage sector.
Related Party Transactions
- Indirect beneficial ownership of common stock through the Michael Kirban 2010 Trust (1,529,049 shares).
- Indirect beneficial ownership of common stock through the Michael Kirban Revocable Trust (615,681 shares).
Stakeholder Impact
- Shareholders: A minor reduction in direct insider ownership, potentially viewed as a slight negative, but mitigated by the pre-arranged 10b5-1 plan.
Next Steps
- Continued vesting of non-qualified stock options, with annual installments for the option with a $26.18 exercise price beginning on March 4, 2025.
- Continued vesting of non-qualified stock options, with annual installments for the option with a $32.78 exercise price beginning on March 3, 2026.
- Expiration of various non-qualified stock options on their respective dates, ranging from December 16, 2029, to March 3, 2035.
Key Dates
| Date | Description |
|---|---|
| 2022-11-27 | Beginning of first annual installment vesting for non-qualified stock option with $15 exercise price. |
| 2024-03-10 | Beginning of first annual installment vesting for non-qualified stock option with $16.91 exercise price. |
| 2025-03-04 | Beginning of first annual installment vesting for non-qualified stock option with $26.18 exercise price. |
| 2025-09-22 | Transaction date for the sale of 20,000 common stock shares. |
| 2025-09-23 | Date the Form 4 was signed and filed. |
| 2026-03-03 | Beginning of first annual installment vesting for non-qualified stock option with $32.78 exercise price. |
| 2029-12-16 | Expiration date for non-qualified stock option with $10.178 exercise price (546,000 shares). |
| 2031-01-11 | Expiration date for non-qualified stock option with $10.178 exercise price (40,950 shares). |
| 2031-10-21 | Expiration date for non-qualified stock option with $15 exercise price. |
| 2033-03-10 | Expiration date for non-qualified stock option with $16.91 exercise price. |
| 2034-03-04 | Expiration date for non-qualified stock option with $26.18 exercise price. |
| 2035-03-03 | Expiration date for non-qualified stock option with $32.78 exercise price. |
Recommendation
holdThis Form 4 filing details a pre-planned sale of a relatively small number of shares by an executive. Such transactions, especially when executed under a 10b5-1 plan, are generally considered routine and do not typically signal a significant change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this filing. Investors should continue to evaluate the company based on its financial performance, strategic initiatives, and broader market conditions.
Keywords
Vita Coco, COCO, Michael Kirban, Insider Trading, Form 4, Stock Sale, Executive Chairman, 10b5-1 Plan, Beneficial Ownership, Stock Options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.